Potent and Selective Non-hydroxamate Histone Deacetylase 8 Inhibitors
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potent and Selective Non-hydroxamate Histone Deacetylase 8 Inhibitors
Authors
Keywords
-
Journal
ChemMedChem
Volume 11, Issue 23, Pages 2598-2606
Publisher
Wiley
Online
2016-11-10
DOI
10.1002/cmdc.201600528
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HDAC8 Inhibition Blocks SMC3 Deacetylation and Delays Cell Cycle Progression without Affecting Cohesin-dependent Transcription in MCF7 Cancer Cells
- (2016) Tanushree Dasgupta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors-What Some May Have Forgotten or Would Rather Forget?
- (2015) Sida Shen et al. ChemMedChem
- Synthesis, Characterization, and Optimization for in Vivo Delivery of a Nonselective Isopeptidase Inhibitor as New Antineoplastic Agent
- (2015) Ulma Cersosimo et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Control Operated by the Cell Cycle Machinery on MEF2 Stability Contributes to the Downregulation of CDKN1A and Entry into S Phase
- (2015) Eros Di Giorgio et al. MOLECULAR AND CELLULAR BIOLOGY
- Investigations of possible prodrug structures for 2-(2-mercaptophenyl)tetrahydropyrimidines: reductive conversion from anti-HIV agents with pyrimidobenzothiazine and isothiazolopyrimidine scaffolds
- (2015) Shiho Okazaki et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Proteomic profiling of lysine acetylation inPseudomonas aeruginosareveals the diversity of acetylated proteins
- (2015) Tassadit Ouidir et al. PROTEOMICS
- Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation
- (2015) I Rettig et al. Cell Death & Disease
- Is there new hope for therapeutic matrix metalloproteinase inhibition?
- (2014) Roosmarijn E. Vandenbroucke et al. NATURE REVIEWS DRUG DISCOVERY
- Evaluation of PD 404,182 as an Anti-HIV and Anti-Herpes Simplex Virus Microbicide
- (2013) Ana M. Chamoun-Emanuelli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The thermodynamic basis for the use of lipophilic efficiency (LipE) in enthalpic optimizations
- (2013) Michael D. Shultz BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Structure–activity relationship study of pyrimido[1,2-c][1,3]benzothiazin-6-imine derivatives for potent anti-HIV agents
- (2012) Tsukasa Mizuhara et al. BIOORGANIC & MEDICINAL CHEMISTRY
- HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle
- (2012) Matthew A. Deardorff et al. NATURE
- Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers
- (2012) Günter Niegisch et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors
- (2011) Lewis Whitehead et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of histone deacetylase 8 selective inhibitors
- (2011) Weiping Tang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Protein acetylation in prokaryotes
- (2011) Joshua D. Jones et al. PROTEOMICS
- Comprehensive lysine acetylomes emerging from bacteria to humans
- (2010) Go-Woon Kim et al. TRENDS IN BIOCHEMICAL SCIENCES
- Efficient Synthesis of Pyrimido[1,2-c] [1,3]benzothiazin-6-imines and Related Tricyclic Heterocycles by SNAr-Type C−S, C−N, or C−O Bond Formation with Heterocumulenes
- (2009) Tsukasa Mizuhara et al. JOURNAL OF ORGANIC CHEMISTRY
- Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
- (2009) C. Choudhary et al. SCIENCE
- Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
- (2008) I. Oehme et al. CLINICAL CANCER RESEARCH
- A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
- (2008) S Balasubramanian et al. LEUKEMIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started